Intellia Therapeutics Inc buy Royal Bank of Canada
Start price
09.08.24
/
50%
€19.65
Target price
09.08.25
€49.44
Performance (%)
-52.65%
End price
10.08.25
€9.30
Summary
This prediction ended on 10.08.25 with a price of €9.30. The BUY prediction by Royal_Bank_of_Canada for Intellia Therapeutics Inc performed very badly with a performance of -52.65%. Royal_Bank_of_Canada has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -3.457% | -3.457% | 31.381% |
| iShares Core DAX® | -1.104% | -6.084% | 3.201% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 20.240% |
| iShares Nikkei 225® | -1.082% | -7.987% | 27.550% |
| iShares S&P 500 | -0.055% | 0.880% | 14.887% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Royal Bank of Canada from $60.00 to $54.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Current prediction by Royal_Bank_of_Canada for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.24
08.08.25
08.08.25
€18.01
08.08.26
08.08.26
20.94%
13.03.26
13.03.26
Stopped prediction by Royal_Bank_of_Canada for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€20.95
19.09.24
19.09.24
€48.55
19.09.25
19.09.25
-35.54%
20.09.25
20.09.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.58
10.11.23
10.11.23
€65.49
10.11.24
10.11.24
-30.16%
11.11.24
11.11.24